Roche Holding AG
SIX:ROG
Roche Holding AG
SIX:ROG
Price:
221.9 CHF
-3.4%
Market Closed
Updated:
Apr 24, 2024
Roche Holding AG
Net Income (Common)
Last
Value
3-Years CAGR
5-Years CAGR
|
Roche Holding AG
Net Income (Common) Peer Comparison
Comparables:
NOVN
NLSP
S
SDZ
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Roche Holding AG
SIX:ROG
|
Net Income (Common)
CHf11.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
|
Novartis AG
SIX:NOVN
|
Net Income (Common)
$14.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Net Income (Common)
-$16.5m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Net Income (Common)
$848m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Net Income (Common)?
Net Income (Common)
11.5B
CHF
11.5B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Net Income (Common) amounts to 11.5B CHF.
What is Roche Holding AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
0%
0%
Over the last year, the Net Income (Common) growth was -7%. The average annual Net Income (Common) growth rates for Roche Holding AG have been -7% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
